Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation.
D000328:Adult; D000914:Antibodies, Viral / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology; D006566:Herpesviridae Infections / Q000628:therapy*; D004854:Herpesvirus 4, Human; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D014412:Tumor Virus Infections / Q000628:therapy*
D000914:Antibodies, Viral; D016756:Immunoglobulins, Intravenous; D016853:Muromonab-CD3; D015774:Ganciclovir